PMC:7247521 / 25638-25893 JSONTXT

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T286","span":{"begin":90,"end":99},"obj":"CHEBI:36357;CHEBI:36357"},{"id":"T287","span":{"begin":242,"end":246},"obj":"CHEBI:23888;CHEBI:23888"}],"text":"re calculated by SwissADME and shown as Fig. 8A. It is worth mentioning that 21 (31.34 %) compounds passed the stringent lead-like criteria (250 g/mol ≤ MW ≤ 350 g/mol, XLOGP ≤ 3.5 and rotatable bonds ≤ 7), which are excellent candidates for drug discover"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T149","span":{"begin":153,"end":155},"obj":"Chemical"},{"id":"T150","span":{"begin":242,"end":246},"obj":"Chemical"}],"attributes":[{"id":"A149","pred":"chebi_id","subj":"T149","obj":"http://purl.obolibrary.org/obo/CHEBI_74709"},{"id":"A150","pred":"chebi_id","subj":"T150","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"}],"text":"re calculated by SwissADME and shown as Fig. 8A. It is worth mentioning that 21 (31.34 %) compounds passed the stringent lead-like criteria (250 g/mol ≤ MW ≤ 350 g/mol, XLOGP ≤ 3.5 and rotatable bonds ≤ 7), which are excellent candidates for drug discover"}